Acadian Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Sell |
10,082
-13,894
| -58% | -$240K | ﹤0.01% | 1321 |
|
|
2025
Q1 | $522K | Buy |
23,976
+22,052
| +1,146% | +$480K | ﹤0.01% | 1073 |
|
|
2024
Q4 | $61K | Hold |
1,924
| – | – | ﹤0.01% | 1431 |
|
|
2024
Q3 | $55K | Buy |
1,924
+1,666
| +646% | +$47.6K | ﹤0.01% | 1766 |
|
|
2024
Q2 | $9K | Hold |
258
| – | – | ﹤0.01% | 1704 |
|
|
2024
Q1 | $15K | Sell |
258
-6
| -2% | -$349 | ﹤0.01% | 1501 |
|
|
2023
Q4 | $15K | Buy |
+264
| New | +$15K | ﹤0.01% | 1605 |
|
|
2021
Q3 | – | Sell |
-3,718
| Closed | -$235K | – | 1704 |
|
|
2021
Q2 | $235K | Buy |
+3,718
| New | +$235K | ﹤0.01% | 1390 |
|